
Enovis Corp (ENOV) Stock Forecast & Price Target
Enovis Corp (ENOV) Analyst Ratings
Bulls say
Enovis is well-positioned in the medical technology industry with a strong portfolio of products that cater to various medical needs, making it a reliable source of revenue and cash flow. Strength in its Extremities and hips and knees segments, as well as the growth of its new products, have contributed to its consistent organic revenue growth. The company's focus on increasing free cash flow conversion and improving operational leverage, along with its attractive entry point and steady performance, make it a promising investment opportunity.
Bears say
Enovis is facing several challenges including slower-than-expected top-line growth, higher contributions from its mature and less attractive P&R segment, and continued tariff pressures. These factors could lead to slower revenue growth, margin compression, and potential difficulties in integrating recent M&A activities. As a result, we believe that Enovis's stock may underperform its peers and face downside risks.
This aggregate rating is based on analysts' research of Enovis Corp and is not a guaranteed prediction by Public.com or investment advice.
Enovis Corp (ENOV) Analyst Forecast & Price Prediction
Start investing in Enovis Corp (ENOV)
Order type
Buy in
Order amount
Est. shares
0 shares